Early Data Released From Phase 1B Duchenne Muscular Dystrophy Gene Therapy Trial
source: pixabay.com

Early Data Released From Phase 1B Duchenne Muscular Dystrophy Gene Therapy Trial

According to a story from BioPortfolio, the drug company Pfizer has recently presented data from its phase 1b clinical trial that tested the company's experimental gene therapy PF-06939926, which is…

Continue Reading Early Data Released From Phase 1B Duchenne Muscular Dystrophy Gene Therapy Trial
For This 4 Year Old With Acute Lymphoblastic Leukemia, Fear of Infection Has Kept Him From Being a Kid
vitalworks / Pixabay

For This 4 Year Old With Acute Lymphoblastic Leukemia, Fear of Infection Has Kept Him From Being a Kid

According to a story from mirror.co.uk, Jack Ruddock, aged four, had always been an endearing and good spirited child, but his life took a dramatic turn when he was hospitalized…

Continue Reading For This 4 Year Old With Acute Lymphoblastic Leukemia, Fear of Infection Has Kept Him From Being a Kid
The IND Approval From The FDA, Experimental Acromegaly Drug Will Enter Phase 3 Trials
peter-facebook / Pixabay

The IND Approval From The FDA, Experimental Acromegaly Drug Will Enter Phase 3 Trials

According to a story from Markets Insider, the biopharmaceutical company Camurus has recently issued an announcement indicating that the US Food and Drug Administration (FDA) has accepted the company's Investigational…

Continue Reading The IND Approval From The FDA, Experimental Acromegaly Drug Will Enter Phase 3 Trials
Baby Makes History as the First Spinal Muscular Atrophy Patient to Receive Gene Therapy Since Its Approval
lisichik / Pixabay

Baby Makes History as the First Spinal Muscular Atrophy Patient to Receive Gene Therapy Since Its Approval

According to a story from BioSpace, on June 7th, 2019, Londyn Wright became the first baby in the US to receive Zolgensma, a recently approved gene therapy treatment for the…

Continue Reading Baby Makes History as the First Spinal Muscular Atrophy Patient to Receive Gene Therapy Since Its Approval
Drug Shows Potential in Treating Hyperkalemia Associated With End-Stage Kidney Disease
jarmoluk / Pixabay

Drug Shows Potential in Treating Hyperkalemia Associated With End-Stage Kidney Disease

According to a story from BioPortfolio, the biopharmaceutical company AstraZeneca recently announced the release of positive results from a phase 3b clinical trial. This trial was testing the safety and…

Continue Reading Drug Shows Potential in Treating Hyperkalemia Associated With End-Stage Kidney Disease
Study Finds Poor Adherence to PDE-5I Drugs Can Have Consequences in Pulmonary Arterial Hypertension
guvo59 / Pixabay

Study Finds Poor Adherence to PDE-5I Drugs Can Have Consequences in Pulmonary Arterial Hypertension

According to a story from Pulmonary Hypertension News, a recent study has found that lapses in treatment adherence can result in serious side effects for pulmonary arterial hypertension (PAH) patients…

Continue Reading Study Finds Poor Adherence to PDE-5I Drugs Can Have Consequences in Pulmonary Arterial Hypertension

How do You Find Strength as Amyotrophic Lateral Sclerosis Causes Your Body to Weaken?

According to a story from princetoninfo.com, Sara Cooper was diagnosed last November with amyotrophic lateral sclerosis. Sara has had an active career as an event planner, marketing consultant, and real…

Continue Reading How do You Find Strength as Amyotrophic Lateral Sclerosis Causes Your Body to Weaken?
Chronic Lymphocytic Leukemia: Patterns of Treatment, Costs, and Adverse Events
1820796 / Pixabay

Chronic Lymphocytic Leukemia: Patterns of Treatment, Costs, and Adverse Events

According to a story from Cancer Therapy Advisor, a recent study published in the journal Cancer Medicine indicated that chronic lymphocytic leukemia (CLL) patients who dealt with adverse events during treatment…

Continue Reading Chronic Lymphocytic Leukemia: Patterns of Treatment, Costs, and Adverse Events
Don’t Miss VWD Connect Foundation’s First-Ever Type 3/Severe Von Willebrand Disease Patient Conference
crystal710 / Pixabay

Don’t Miss VWD Connect Foundation’s First-Ever Type 3/Severe Von Willebrand Disease Patient Conference

Von Willebrand disease is the most common inherited blood clotting disorder that affects humans. The disorder can also be acquired. Although it is considered common, the majority of cases do…

Continue Reading Don’t Miss VWD Connect Foundation’s First-Ever Type 3/Severe Von Willebrand Disease Patient Conference